Article
Patients with prolonged effect of succinylcholine or mivacurium had novel mutations in the butyrylcholinesterase gene.
Pharmacogenetics and genomics - 1 Jul 2016
Wichmann Sine, Færk Gitte, Bundgaard Jens R, Gätke Mona R
Abstract excerpt
INTRODUCTION: Mutations in the butyrylcholinesterase enzyme (BChE) can result in prolonged duration of action of the neuromuscular blocking agents, succinylcholine and mivacurium, as BChE hydrolyses these drugs. Hereditary low BChE activity can cause extensively prolonged apnoea during general anaesthesia when these drugs are used. The aim of this study was to describe novel mutations in the butyrylcholinesterase...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
